Medicines for the treatment of diseases of the blood, blood-forming organs and diseases of the cardiovascular system, namely: epinephrine 1.82 mg/ml, solution for injection, ampoule; aminocaproic acid, solution for infusion, 50 mg/ml, 100 ml...
TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Description & Project Overview
Medicines for the treatment of diseases of the blood, blood-forming organs and diseases of the cardiovascular system, namely: epinephrine 1.82 mg/ml, solution for injection, ampoule; aminocaproic acid, solution for infusion, 50 mg/ml, 100 ml each; amiodarone, solution for injection, 50 mg/ml, 3 ml each; metamizole sodium, solution for injection, 500 mg/ml, 2 ml; potassium aspartate/magnesium aspartate solution for injection 5 ml each; atropine sulfate solution for injection 1 mg/1 ml, in 1 ml ampoule; acetylsalicylic acid tablets 500 mg each; barbiturates in combination (ethyl ester of alpha-bromoisovaleric acid 18 mg, phenobarbital 17 mg, solution of menthol in menthyl ester of isovaleric acid 80 mg) oral drops 25 ml each; heparin sodium, solution for injection, 5000 IU/ml, 5 ml each; glucose solution for injection 40% 20 ml each; glucose solution for infusion 5% 200 ml each; dexamethasone, solution for injection 4 mg/ml; dexketoprofen solution for injection 25 mg/ml 2 ml each; diclofenac solution for injection 25 mg/ml; diphenhydramine, solution for injection, 10 mg/ml, 1 ml each; drotaverine solution for injection 20 mg/ml, 2 ml in ampoule; isosorbide, spray, 1.25 mg/dose, 15 ml each; paracetamol solution for infusion 10 mg/ml 100 ml; calcium gluconate solution for injection 100 mg/ml 5 ml each; captopril/hydrochlorothiazide, tablets, 50/12.5 mg each; ketorolac solution for injection, 30 mg/ml, 1 ml each; caffeine sodium benzoate, solution for injection, 100 mg/ml, 1 ml each; chloramphenicol/methyluracil ointment 7.5 mg/40 mg 40 g each; lidocaine, solution for injection, 100 mg/ml, 2 ml each; lidocaine, spray, 10%, 38 g each; balsamic liniment according to Vishnevsky 40 g each; magnesium sulfate, solution for injection, 250 mg/ml, 10 ml each; hydrocortisone butyrate, cream, 1 mg/g, 30 g each; metoclopramide, solution for injection, 5 mg/ml, 2 ml each; sodium thiosulfate solution for injection 300 mg/ml 5 ml; sodium chloride, solution for infusion, 9 mg/ml 200 ml; sodium chloride, solution for injection, 9 mg/ml, 5 ml each; ondansetron solution for injection 2 mg/ml 2 ml each; papaverine, solution for injection, 20 mg/ml, 2 ml each; hydrogen peroxide, solution, 3%, 100 ml each; piracetam, solution for injection, 200 mg/ml, 5 ml each; platyphyllin solution for injection, 2 mg/ml, 1 ml each; dabigatran etexilate hard capsules 150 mg each; prednisolone, solution for injection, 30 mg/ml, 1 ml each; electrolytes in combination with sorbitol 60 mg/1 ml solution for infusion 200 ml each; inosine, solution for injection, 20 mg/ml, 10 ml each; salbutamol, pressurised inhalation, 100 mcg/dose, 200 doses each; dexpanthenol cutaneous foam 50 mg/g 116 g each; sulfacamphocaine solution for injection, 100 mg/ml 2 ml each; chloropyramine, solution for injection, 20 mg/ml, 1 ml each; furosemide, solution for injection, 10 mg/ml, 2 ml each; tranexamic acid solution for injection, 100 mg/ml 5 ml each; Trisol solution for infusion 200 ml each; chlorhexidine, solution for external use 0.05% 100 ml each; theophylline solution for injection 20 mg/ml 5 ml each
Related Procurement Opportunities
Similar tenders in Pharmaceuticals, Healthcare and Medicine, Chemicals